Connection

Helmut Albrecht to Pyrrolidinones

Back to Details
This is a "connection" page, showing publications Helmut Albrecht has written about Pyrrolidinones.
Helmut Albrecht
Connection Strength
0.699
Pyrrolidinones
  1. Raltegravir--beauty and the beast. Both the advantages and the limitations of this integrase inhibitor were evident this year. J Watch AIDS Clin Care. 2010 Jan; 22(1):4.
    View in: PubMed
    Score: 0.344
  2. Report from the 16th Conference on Retroviruses and Opportunistic Infections. SWITCHMRK: an avoidable raltegravir disaster. J Watch AIDS Clin Care. 2009 Apr; 21(4):30-1.
    View in: PubMed
    Score: 0.327
  3. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.